Private networks transitioning from connectivity platforms to intelligent automation infrastructure across manufacturing, ...

CAMBRIDGE, England & STEVENAGE, England--(BUSINESS WIRE)--Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and ...

Manufacturers can leverage private 4G LTE and 5G NR cellular networks to realize industrial IoT connectivity. How do private and public cellular networks differ? Is a private network the right fit for ...

Cell culture and cellular applications have been and continue to be essential to medical and biological research. By automating these assays, researchers can reduce their time at the bench while ...

Although manufacturing is a core enabler of the Internet of Things, many industrial companies don't fully understand the capabilities of the cellular communications technology that can enable it.

Smart Manufacturing Cellular IoT Connectivity to Generate $4.9 billion in Revenue by 2028 as Automation & Maintenance Drive Investments in Digital A new report from Kaleido Intelligence, a leading ...

Fresenius Kabi and Cellular Origins have announced a partnership to advance the field of cell and gene therapy (CGT) by automating the manufacturing process. Fresenius Kabi's cell therapy processing ...

Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs ...

With 4G LTE support for multiple North American carriers in each unit, customers using Red Lion's RAM cellular RTUs and IndustrialPro routers can easily select and switch between wireless carriers to ...

The domains of wireless and cellular connections in automation have long been distinct entities. But just as your smartphone easily toggles between cellular and Wi-Fi, automation systems are beginning ...

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an ...